• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Use of weight reduction interventions for overweight and obese patients limited in UK primary care

byMia KanakandRavi Shah
January 16, 2015
in Chronic Disease, Public Health
Reading Time: 3 mins read
Colonic byproduct may decrease long-term weight gain
Share on FacebookShare on Twitter

1. Most overweight and obese patients had not received weight reduction interventions according to primary care electronic records.

2. The most common weight reduction intervention in the primary care setting for overweight and obese patients was lifestyle advising, compared to prescription anti-obesity drugs for morbidly obese patients.

Evidence Rating Level: 2 (Good)

Study Rundown: Studies have shown that weight reduction interventions in primary care settings can be effective at managing obesity. The authors of this study aimed to examine the use of weight management interventions (e.g. lifestyle counseling, referral for weight management or bariatric surgery, prescription drugs) by primary care physicians in the United Kingdom (UK). They found that the large majority of overweight and obese patients had no record of receiving a weight reduction. The most commonly recorded intervention for overweight and obese patients was lifestyle counseling. Among morbidly obese patients the most common intervention was use of prescription drugs. Interestingly, no significant differences were found in weight change over 5 years among patients who received any of the three interventions types.

This study had a strong study design as it used a sample size of over 90,000 patients from the largest primary care database in the world. It supports a previous survey-based study that found limited use of obesity management interventions in the UK primary care setting. A notable limitation is that access to weight loss interventions was determined using electronic medical records, which are not always accurate as the study also found significant variation among primary care office documenting practices. Overall, the results reinforce previous findings of missed opportunities for weight loss interventions in the primary care setting. Efforts to increase access to weight management services in the primary care arena may be an effective public health strategy to combat obesity.

Click to read the study in BMJ Open

RELATED REPORTS

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

Sleep restriction promotes weight gain in high-risk adults 

Biweekly glucagon-like peptide-1 receptor agonist bofanglutide improves glycemic control

Relevant Reading: Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force

In-Depth [retrospective cohort]: Records of 91,413 individuals between age 30-100 and a BMI ≥ 25 were randomly selected from the Clinical Practice Research Datalink, the largest primary care database in the world based in the UK. All patients were registered with a primary care practice for at least one year between 2005 and 2012. Patient weights were classified according to World Health Organization classifications of BMI (overweight 25-29.9, obese 30-34.9, severe obesity 35-39.9, and morbid obesity ≥ 40). Medical record codes were examined to determine the use of weight management interventions. The cohort consisted of 60% overweight and 40% obese patients. The median proportion of patients who received a weight management intervention was 12%. Those with lower BMI were less likely to receive an intervention; for example, of the women in the study, the rate of no treatment ranged from 58% among morbidly obese patients to 90% among overweight patients. This relationship was confirmed with a multivariable analysis, which found that BMI category was the most strongly associated with weight loss intervention (hazard ratio 3.67, CI95% 3.45-3.92 for morbid obesity). Older age, female gender, depression, type 2 diabetes, former smoking status, and low socioeconomic status were also associated with weight management treatment.

More from this author: Unhealthy food cues prominent in children’s programming in the UK and Ireland, BCG vaccine protective against active tuberculosis in children, U.S. firearm fatality rates differ by state, race, and ethnicity, Smokers’ support for plain tobacco packaging linked to desire to quit, UK primary care physicians frequently prescribing antipsychotics for non-psychotic disorders

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: BMIobesityoverweight
Previous Post

Genetic mutation identified that underlies familial myelodysplastic syndrome [PreClinical]

Next Post

Hypoxia biomarker may predict distant recurrence in pancreatic cancer

RelatedReports

Increasing maternal BMI linked to higher risk of cerebral palsy
Endocrinology

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

August 31, 2026
Sleep duration inversely related to childhood type 2 diabetes risk makers
Chronic Disease

Sleep restriction promotes weight gain in high-risk adults 

July 6, 2026
Endocrinology

Biweekly glucagon-like peptide-1 receptor agonist bofanglutide improves glycemic control

June 29, 2026
Many new pediatric asthma cases attributable to obesity
Cardiology

150 minutes of moderate-to-vigorous physical activity per week may reduce cardiovascular risk in overweight or obese adults

February 26, 2026
Next Post
Hypoxia biomarker may predict distant recurrence in pancreatic cancer

Hypoxia biomarker may predict distant recurrence in pancreatic cancer

Perfusion imaging may predict successful thrombolysis for acute stroke

Turmeric associated with fewer neural tube defects in mice

Turmeric associated with fewer neural tube defects in mice

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.